(Photo: iStock)

The H2-antagonists including Cimetidine, Famotidine, and Nizatidine are facing supply disruption. Latest update on the supply of these products is given below…

Product Supplier Current Stock Position Anticipated Resupply date Detail
Famotidine 20mg tablets Tilomed Laboratories Limited supplies Early December 2020 Unlicensed supplies have been sourced
Teva UK Out of stock Mid November 2020
Famotidine 40mg tablets Tilomed Laboratories In stock N/A
Teva UK Limited supplies End November 2020
Cimetidine 200mg tablets Ennogen Pharma Out of stock June 2021 Unlicensed supplies have been sourced
Medreich Out of stock to be confirmed
Cimetidine 400mg tablets Ennogen Pharma Out of stock June 2021
Medreich Out of stock to be confirmed
Cimetidine 800mg tablets Ennogen Pharma Out of stock June 2021
Medreich Out of stock to be confirmed
Cimetidine 200mg/5ml oral solution Rosemont Pharmaceuticals In stock n/a
Nizatidine 150mg tablets Mylan Out of stock Early January 2021 Unlicensed supplies have been sourced
Medreich Out of stock to be confirmed
Relonchem Out of stock End November 2020
Nizatidine 300mg tablets Mylan Out of stock Early January 2021 Unlicensed supplies of Nizatidine 150mg capsules have been sourced
Medreich Out of stock to be confirmed
Relonchem Out of stock In stock

 

Alium Medical,  Mawdsley’s Unlicensed, Durbin PLC, and Target Healthcare have confirmed that they can source unlicensed Cimetidine 200mg, 400mg, and 800mg tablets. The three drug manufacturers have also assured that they can supply Famotidine tablets 20mg and 40mg

Ennogen and UL Global will be able to supply Cimetidine 200mg, 400mg and famotidine 20mg and 40mg tablets respectively to avert any severe scarcity of the medicines.

Mawdsley’s Unlicensed and Target Healthcare have confirmed that they can source unlicensed Nizatidine capsules.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine tablets cannot be issued.

If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY